Literature DB >> 23467775

Interleukin-21 overexpression dominates T cell response to Epstein-Barr virus in a fatal case of X-linked lymphoproliferative syndrome type 1.

Consuelo Ortega1, Orlando A Estévez, Silvia Fernández, Rocío Aguado, José M Rumbao, Teresa Gonzalez, Juan L Pérez-Navero, Manuel Santamaría.   

Abstract

Interleukin-21 (IL-21) is a cytokine whose actions are closely related to B cell differentiation into plasma cells as well as to CD8(+) cytolytic T cell effector and memory generation, influencing the T lymphocyte response to different viruses. X-linked lymphoproliferative syndrome type 1 (XLP-1) is a primary immunodeficiency syndrome that is characterized by a high susceptibility to Epstein-Barr virus. We observed in a pediatric patient with XLP-1 that IL-21 was expressed in nearly all peripheral blood CD4(+) and CD8(+) T cells. However, IL-21 could not be found in the lymph nodes, suggesting massive mobilization of activated cells toward the infection's target organs, where IL-21-producing cells were detected, resulting in large areas of tissue damage.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23467775      PMCID: PMC3647751          DOI: 10.1128/CVI.00002-13

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN: 1556-679X


  36 in total

Review 1.  SAP: a molecular switch regulating the immune response through a unique signaling mechanism.

Authors:  André Veillette
Journal:  Eur J Immunol       Date:  2003-05       Impact factor: 5.532

2.  Regulation of NKT cell development by SAP, the protein defective in XLP.

Authors:  Kim E Nichols; Jamie Hom; Shun-You Gong; Arupa Ganguly; Cindy S Ma; Jennifer L Cannons; Stuart G Tangye; Pamela L Schwartzberg; Gary A Koretzky; Paul L Stein
Journal:  Nat Med       Date:  2005-02-13       Impact factor: 53.440

3.  Fatal infectious mononucleosis in a family.

Authors:  R S Bar; C J DeLor; K P Clausen; P Hurtubise; W Henle; J F Hewetson
Journal:  N Engl J Med       Date:  1974-02-14       Impact factor: 91.245

Review 4.  Interleukin-21 and the IL-21 receptor: novel effectors of NK and T cell responses.

Authors:  Julia Parrish-Novak; Donald C Foster; Richard D Holly; Christopher H Clegg
Journal:  J Leukoc Biol       Date:  2002-11       Impact factor: 4.962

Review 5.  Interleukin 21: a key player in lymphocyte maturation.

Authors:  Stephen L Nutt; Jason Brady; Yoshihiro Hayakawa; Mark J Smyth
Journal:  Crit Rev Immunol       Date:  2004       Impact factor: 2.214

6.  SAP regulates T(H)2 differentiation and PKC-theta-mediated activation of NF-kappaB1.

Authors:  Jennifer L Cannons; Li J Yu; Brenna Hill; Lilia A Mijares; Derek Dombroski; Kim E Nichols; Anthony Antonellis; Gary A Koretzky; Kevin Gardner; Pamela L Schwartzberg
Journal:  Immunity       Date:  2004-11       Impact factor: 31.745

7.  Defective NK cell activation in X-linked lymphoproliferative disease.

Authors:  L Benoit; X Wang; H F Pabst; J Dutz; R Tan
Journal:  J Immunol       Date:  2000-10-01       Impact factor: 5.422

8.  X-linked recessive progressive combined variable immunodeficiency (Duncan's disease).

Authors:  D T Purtilo; C K Cassel; J P Yang; R Harper
Journal:  Lancet       Date:  1975-04-26       Impact factor: 79.321

9.  Synergy of IL-21 and IL-15 in regulating CD8+ T cell expansion and function.

Authors:  Rong Zeng; Rosanne Spolski; Steven E Finkelstein; SangKon Oh; Panu E Kovanen; Christian S Hinrichs; Cynthia A Pise-Masison; Michael F Radonovich; John N Brady; Nicholas P Restifo; Jay A Berzofsky; Warren J Leonard
Journal:  J Exp Med       Date:  2005-01-03       Impact factor: 14.307

10.  SAP controls the cytolytic activity of CD8+ T cells against EBV-infected cells.

Authors:  Loïc Dupré; Grazia Andolfi; Stuart G Tangye; Rita Clementi; Franco Locatelli; Maurizio Aricò; Alessandro Aiuti; Maria-Grazia Roncarolo
Journal:  Blood       Date:  2005-01-27       Impact factor: 22.113

View more
  1 in total

Review 1.  Epstein-Barr Virus and Helicobacter Pylori Co-Infection in Non-Malignant Gastroduodenal Disorders.

Authors:  Ramsés Dávila-Collado; Oscar Jarquín-Durán; Le Thanh Dong; J Luis Espinoza
Journal:  Pathogens       Date:  2020-02-06
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.